# Liminal BioSciences Inc. (LMNL)

Source: https://www.quantisnow.com/company/LMNL
Generated: 2026-11-12T13:43:21.622Z

- Ticker: LMNL
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: liminalbiosciences.com

## About

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma-Derived Therapeutics. The Small Molecule Therapeutics segment's lead product candidate is fezagepras (PBI-4050), which is in Phase 1 for the treatment of idiopathic pulmonary fibrosis and respiratory diseases. The Plasma-Derived Therapeutics segment focused on the development of its plasma-derived product candidate Ryplazim, a purified glu-plasminogen derived from human plasma that acts as a plasminogen replacement therapy for patients deficient in plasminogen protein. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.

## Latest LMNL news and filings

- 2023-10-06 12:30 UTC [SEC Form 15-12G filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-liminal-biosciences-inc-5008476)
- 2023-09-27 20:05 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Liminal BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-liminal-biosciences-inc-amendment-4990688)
- 2023-09-27 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-liminal-biosciences-inc-4989277)
- 2023-09-27 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-liminal-biosciences-inc-4989272)
- 2023-09-27 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-liminal-biosciences-inc-4989266)
- 2023-09-26 13:12 UTC [SEC Form POS AM filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-liminal-biosciences-inc-4987853)
- 2023-09-26 13:07 UTC [SEC Form POS AM filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-liminal-biosciences-inc-4987843)
- 2023-09-26 13:04 UTC [SEC Form POS AM filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-liminal-biosciences-inc-4987825)
- 2023-09-26 12:57 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-liminal-biosciences-inc-4987724)
- 2023-09-26 12:55 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4987720)
- 2023-09-26 12:54 UTC [SEC Form SC 13E3/A filed by Liminal BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-liminal-biosciences-inc-amendment-4987715)
- 2023-09-26 12:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4987572)
- 2023-09-26 12:00 UTC [LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP](https://www.quantisnow.com/insight/liminal-biosciences-announces-completion-of-the-plan-of-arrangement-with-4987449)
- 2023-09-19 20:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4978700)
- 2023-09-19 20:23 UTC [Market Chatter] [Liminal Biosciences Receives Final Court Order For Plan Of Arrangement With Structured Alpha LP](https://www.quantisnow.com/insight/liminal-biosciences-receives-final-court-order-for-plan-of-arrangement-4978548)
- 2023-09-19 20:22 UTC [LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP](https://www.quantisnow.com/insight/liminal-biosciences-receives-final-court-order-for-plan-of-arrangement-4978535)
- 2023-09-15 16:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4973105)
- 2023-09-15 15:29 UTC [LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP](https://www.quantisnow.com/insight/liminal-biosciences-shareholders-approve-plan-of-arrangement-with-structured-alpha-4973041)
- 2023-09-12 12:38 UTC [SEC Form SC 13E3/A filed by Liminal BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-liminal-biosciences-inc-amendment-4965712)
- 2023-09-12 12:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4965580)
- 2023-09-12 11:45 UTC [LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR](https://www.quantisnow.com/insight/liminal-biosciences-files-amended-schedule-13e-3-and-supplement-to-the-4965438)
- 2023-08-17 01:28 UTC [SEC Form SC 13E3 filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-sc-13e3-filed-by-liminal-biosciences-inc-4909107)
- 2023-08-17 01:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4909102)
- 2023-08-16 21:20 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4908131)
- 2023-08-16 20:48 UTC [Market Chatter] [Liminal BioSciences Secures Interim Order For Proposed Arrangement With Structured Alpha LP](https://www.quantisnow.com/insight/liminal-biosciences-secures-interim-order-for-proposed-arrangement-with-structured-4907782)
- 2023-08-16 20:46 UTC [LIMINAL BIOSCIENCES OBTAINS INTERIM ORDER FOR PROPOSED ARRANGEMENT WITH STRUCTURED ALPHA LP](https://www.quantisnow.com/insight/liminal-biosciences-obtains-interim-order-for-proposed-arrangement-with-structured-4907762)
- 2023-08-08 22:11 UTC [Market Insight] [Liminal BioSciences Reports Q2 Financial Results 2023 Cash And Cash Equivalents Were $19.3M At June 30, 2023](https://www.quantisnow.com/insight/liminal-biosciences-reports-q2-financial-results-2023-cash-and-cash-4865447)
- 2023-08-08 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4863632)
- 2023-08-08 20:05 UTC [Liminal BioSciences Reports Second Quarter Financial Results 2023](https://www.quantisnow.com/insight/liminal-biosciences-reports-second-quarter-financial-results-2023-4863242)
- 2023-08-02 20:41 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4836259)
- 2023-07-12 23:09 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Liminal BioSciences Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-liminal-biosciences-inc-amendment-4748842)
- 2023-07-12 21:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4748176)
- 2023-07-12 16:53 UTC [Market Insight] [Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-lucid-group-shares-are-trading-lower-by-11-here-4746437)
- 2023-07-12 16:39 UTC [Market Insight] [Liminal BioSciences Stock Gains0% Today - Here's Why?](https://www.quantisnow.com/insight/liminal-biosciences-stock-gains0-today---heres-why-4746367)
- 2023-07-12 12:33 UTC [Market Chatter] [Liminal BioSciences shares are trading higher after the company announced it entered into an arrangement agreement with Structured Alpha LP. Liminal minority shareholders are to receive $8.50 in cash per share in "go private" transaction](https://www.quantisnow.com/insight/liminal-biosciences-shares-are-trading-higher-after-the-company-announced-4744779)
- 2023-07-12 11:50 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4744369)
- 2023-07-12 11:33 UTC [Market Chatter] [Liminal BioSciences Enters Arrangement Agreement With Structured Alpha LP; Minority Shareholders To Receive $8.50 In Cash Per Share In "Go Private" Transaction](https://www.quantisnow.com/insight/liminal-biosciences-enters-arrangement-agreement-with-structured-alpha-lp-minority-4744296)
- 2023-07-12 11:30 UTC [Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP](https://www.quantisnow.com/insight/liminal-biosciences-announces-arrangement-agreement-with-structured-alpha-lp-4744275)
- 2023-06-05 20:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by Liminal BioSciences Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-liminal-biosciences-inc-4603210)
- 2023-06-05 20:05 UTC [Leadership Update] [Liminal BioSciences Announces Voting Results of its 2023 Annual General Meeting of Shareholders](https://www.quantisnow.com/insight/liminal-biosciences-announces-voting-results-of-its-2023-annual-general-4603027)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LMNL
- Earnings history: https://www.quantisnow.com/earnings/LMNL
- Dividend history: https://www.quantisnow.com/dividends/LMNL
- Insider transactions: https://www.quantisnow.com/insiders/LMNL
- Options chain: https://www.quantisnow.com/options/LMNL
- SEC 8-K filings only: https://www.quantisnow.com/company/LMNL/8-k
- RSS and alerts for LMNL: https://www.quantisnow.com/docs/rss-feeds.md